Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of PAC-14028 Cream in Healthy Volunteers
NCT02309008Phase 1Completed
- Sponsor
- Amorepacific Corporation
- Start
- Nov 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in atopic dermatitis (AD) comparing Placebo with Asivatrep (2 arms). Primary endpoint: Safety and Tolerability. Started Nov 2014; status: completed.
02
Drugs
asivatrep
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02309008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02309008.